Timentin

Company: SmithKline Beecham
Approval Status: Approved December 1997
Treatment for: septicemia
Areas: Pediatrics
Possible similar drugs: Timentin

| General Information |

General Information

Timentin, a Ticarcillin disodium and clavulante potassium injection, has been approved for use in children three months to 16 years of age.

< back to top

Timentin Drug Information

The Timentin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.